Coexistence of autoimmunological diseases does not affect safety of immunotherapy in hymenoptera allergic patients

被引：0
|
作者：
Kempinski, K. [1 ]
Kita, K. [1 ]
Niedoszytko, M. [1 ]
Gorska, L. [1 ]
Jassem, E. [1 ]
机构：
[1] Med Univ Gdansk, Gdansk, Poland
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
  • [31] Does our sleep debt affect patients' safety?
    Tewari, Anurag
    Soliz, Jose
    Billota, Federico
    Garg, Shuchita
    Singh, Harsimran
    INDIAN JOURNAL OF ANAESTHESIA, 2011, 55 (01) : 12 - 17
  • [32] Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
    Kim, Harold
    Waserman, Susan
    Hebert, Jacques
    Blaiss, Michael
    Nelson, Harold
    Creticos, Peter
    Kaur, Amarjot
    Maloney, Jennifer
    Li, Ziliang
    Nolte, Hendrik
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
  • [33] Does Allergen-Specific Immunotherapy Prevent New Sensitizations in Childhood Allergic Airway Diseases?
    Dilek, Emine
    Bag, Ozlem
    Altinoz, Serdar
    Asilsoy, Suna
    Ozturk, Aysel
    Can, Demet
    ASTIM ALLERJI IMMUNOLOJI, 2018, 16 (01): : 34 - 39
  • [34] Venom Immunotherapy Does Not Affect Survival of Patients with Malignant Tumor in Poland
    Chelminska, Marta
    Specjalski, Krzysztof
    Jassem, Ewa
    Polanska, Joanna
    Kita, Karolina
    Gorska, Lucyna
    Didkowska, Joanna
    Wojciechowska, Urszula
    Nittner-Marszalska, Marita
    Kuna, Piotr
    Kupczyk, Maciej
    Kruszewski, Jerzy
    Zakrzewski, Aleksander
    Czarnobilska, Ewa
    Stobiecki, Marcin
    Krenke, Rafal
    Dabrowski, Andrzej
    Kwasniewski, Artur
    Jarzab, Jerzy
    Bozek, Andrzej
    Bodzenta-Lukaszyk, Anna
    Lukaszyk, Mateusz
    Kowalski, Marek
    Smorawska-Sabanty, Ewa
    Fal, Andrzej
    Przybylowska, Katarzyna
    Bartuzi, Zbigniew
    Palgan, Krzysztof
    Niedoszytko, Marek
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [35] CLINICAL EFFECTS OF IMMUNOTHERAPY IN PATIENTS WITH ALLERGIC DISEASE IN THE NATIONAL INSTITUTE OF RESPIRATORY DISEASES
    Ma del Rosario, G. G.
    Garcia Cruz, M. H.
    Ruiz Cervantes, K.
    Najera Villatoro, C.
    Ramirez, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A120 - A120
  • [36] Patients' and physicians' perspectives on safety and efficacy of allergen specific immunotherapy for allergic rhinitis
    Sarkunaite, R.
    Staikuniene, J.
    ALLERGY, 2021, 76 : 50 - 50
  • [37] Safety and Efficacy of Allergen Immunotherapy in Patients with HIV and Allergic Rhinitis: Facts and Fiction
    Alam S.
    Calderon M.A.
    Current Treatment Options in Allergy, 2015, 2 (1) : 32 - 38
  • [38] Safety of an ultra-rush desensitisation protocol in Hymenoptera-venom allergic patients
    Reis Ferreira, A.
    Barreira, P.
    Moreira da Silva, J.
    Coimbra, A.
    Placido, J.
    ALLERGY, 2012, 67 : 406 - 406
  • [39] Safety of mRNA COVID-19 vaccinations in patients with allergic diseases
    Rosada, Tomasz
    Napiorkowska-Baran, Katarzyna
    Cala, Lukasz
    Alska, Ewa
    Paulina, Kesicka
    Czarnowska, Marta
    Bartuzi, Zbigniew
    PUBLIC HEALTH IN PRACTICE, 2023, 5
  • [40] The efficacy and safety of allergen immunotherapy in patients with mast cell disorders and hymenoptera venom anaphylaxis
    Salehi, C.
    Jarkvist, J.
    Nilsson, G.
    Akin, C.
    Gulen, T.
    ALLERGY, 2018, 73 : 69 - 69
12345